Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers

Abstract

While mortality rates among HIV-infected individuals at our centre have fallen since 1988, the deaths that do now occur are more diverse and are the result of a number of factors, including late presentation, delayed uptake of HAART and the previous use of treatment combinations that are now viewed as suboptimal.